Terry Gramlich

4.5k total citations · 2 hit papers
22 papers, 3.5k citations indexed

About

Terry Gramlich is a scholar working on Epidemiology, Hepatology and Pathology and Forensic Medicine. According to data from OpenAlex, Terry Gramlich has authored 22 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 14 papers in Hepatology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Terry Gramlich's work include Liver Disease Diagnosis and Treatment (19 papers), Hepatitis C virus research (11 papers) and Liver Disease and Transplantation (7 papers). Terry Gramlich is often cited by papers focused on Liver Disease Diagnosis and Treatment (19 papers), Hepatitis C virus research (11 papers) and Liver Disease and Transplantation (7 papers). Terry Gramlich collaborates with scholars based in United States, Australia and Argentina. Terry Gramlich's co-authors include Zobair M. Younossi, Janus P. Ong, Arthur J. McCullough, Kevin D. Mullen, James N. Cooper, Erick M. Remer, Sherif Saadeh, M Hurley, Michael J. Sheridan and Navdeep Boparai and has published in prestigious journals such as Gastroenterology, Hepatology and The American Journal of Medicine.

In The Last Decade

Terry Gramlich

21 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The utility of radiological imaging in nonalcoholic fatty liver disease

2002 1.6k citations Sherif Saadeh, Zobair M. Younossi et al. Gastroenterology profile →
Long-Term Follow-Up of Patients With Nonalcoholic Fatty Liver

2008 583 citations Nila Rafiq, Chunhong Bai et al. Clinical Gastroenterology and Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Terry Gramlich United States	14	3.1k	1.5k	1.4k	631	541	22	3.5k
L. Miglioli Italy	14	3.4k 1.1×	1.3k 0.9×	1.7k 1.2×	770 1.2×	482 0.9×	27	3.8k
Alita Mishra United States	25	2.6k 0.8×	1.7k 1.1×	790 0.6×	451 0.7×	523 1.0×	42	3.1k
Fatema Nader United States	29	3.4k 1.1×	2.2k 1.5×	1.3k 0.9×	383 0.6×	456 0.8×	76	3.9k
Christine G. Janney United States	17	4.3k 1.4×	2.0k 1.3×	1.6k 1.2×	795 1.3×	1.2k 2.2×	36	5.3k
Nila Rafiq United States	16	2.8k 0.9×	1.4k 0.9×	1.3k 0.9×	554 0.9×	491 0.9×	26	3.1k
Manirath Srishord United States	13	3.6k 1.1×	1.6k 1.0×	1.8k 1.2×	668 1.1×	606 1.1×	28	4.0k
Luis Calzadilla Bertot Australia	16	3.2k 1.0×	1.6k 1.1×	1.5k 1.0×	471 0.7×	564 1.0×	38	3.6k
Janet C. Shaw United States	7	1.9k 0.6×	825 0.6×	855 0.6×	338 0.5×	496 0.9×	9	2.4k
Sushma Saksena United Kingdom	10	2.4k 0.8×	1.5k 1.0×	866 0.6×	365 0.6×	495 0.9×	22	2.6k
Diana Barb United States	20	2.8k 0.9×	938 0.6×	1.5k 1.1×	352 0.6×	536 1.0×	31	3.5k

Countries citing papers authored by Terry Gramlich

Since Specialization

Citations

This map shows the geographic impact of Terry Gramlich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Terry Gramlich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Terry Gramlich more than expected).

Fields of papers citing papers by Terry Gramlich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Terry Gramlich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Terry Gramlich. The network helps show where Terry Gramlich may publish in the future.

Co-authorship network of co-authors of Terry Gramlich

This figure shows the co-authorship network connecting the top 25 collaborators of Terry Gramlich. A scholar is included among the top collaborators of Terry Gramlich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Terry Gramlich. Terry Gramlich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Baranova, Ancha, Mohammed Jarrar, Maria Stepanova, et al.. (2010). Association of Serum Adipocytokines with Hepatic Steatosis and Fibrosis in Patients with Chronic Hepatitis C. Digestion. 83(1-2). 32–40. 21 indexed citations

Rafiq, Nila, Chunhong Bai, Yun Fang, et al.. (2008). Long-Term Follow-Up of Patients With Nonalcoholic Fatty Liver. Clinical Gastroenterology and Hepatology. 7(2). 234–238. 583 indexed citations breakdown →

Younossi, Zobair M., David S. Barnes, Anthony B. Post, et al.. (2005). Pegylated Interferon α-2b, Ribavirin and Amantadine for Chronic Hepatitis C. Digestive Diseases and Sciences. 50(5). 970–975. 13 indexed citations

Younossi, Zobair M., et al.. (2004). Nonalcoholic fatty liver disease in patients with type 2 diabetes. Clinical Gastroenterology and Hepatology. 2(3). 262–265. 334 indexed citations

Sarbah, Steedman, Terry Gramlich, Abraham Younoszai, et al.. (2004). Risk Factors for Hepatocellular Carcinoma in Patients with Cirrhosis. Digestive Diseases and Sciences. 49(5). 850–853. 31 indexed citations

Younossi, Zobair M., Kevin D. Mullen, David S. Barnes, et al.. (2003). Triple Combination of Interferon Alpha-2b, Ribavirin, and Amantadine for Treatment of Chronic Hepatitis C. Journal of Clinical Gastroenterology. 36(5). 427–430. 9 indexed citations

Younossi, Zobair M., Arthur J. McCullough, Janus P. Ong, et al.. (2003). Interaction of steatosis and non-alcoholic steatohepatitis (NASH) with chronic hepatitis C. Gastroenterology. 124(4). A745–A745. 1 indexed citations

Saadeh, Sherif, Zobair M. Younossi, Erick M. Remer, et al.. (2002). The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology. 123(3). 745–750. 1633 indexed citations breakdown →

Aggarwal, Anjana, et al.. (2001). Mushroom poisoning-from diarrhea to liver transplantation. The American Journal of Gastroenterology. 96(11). 3195–3198. 127 indexed citations

10.

Ong, Janus P., Zobair M. Younossi, Terry Gramlich, et al.. (2001). INTERFERON?? 2B AND RIBAVIRIN IN SEVERE RECURRENT CHOLESTATIC HEPATITIS. Transplantation. 71(10). 1486–1488. 21 indexed citations

11.

Ong, Janus P., et al.. (2001). Chronic hepatitis C and superimposed nonalcoholic fatty liver disease. Liver International. 21(4). 266–271. 126 indexed citations

12.

Younossi, Zobair M., Kevin D. Mullen, David S. Barnes, et al.. (2001). A randomized, double-blind controlled trial of interferon alpha-2b and ribavirin vs. interferon alpha-2b and amantadine for treatment of chronic hepatitis C non-responder to interferon monotherapy. Journal of Hepatology. 34(1). 128–133. 36 indexed citations

13.

Shen, Bo, Zobair M. Younossi, Bart L. Dolmatch, et al.. (2001). Patent ductus venosus in an adult presenting as pulmonary hypertension, right-sided heart failure, and portosystemic encephalopathy. The American Journal of Medicine. 110(8). 657–660. 16 indexed citations

14.

Younossi, Zobair M., Terry Gramlich, Bruce R. Bacon, et al.. (1999). Hepatic iron and nonalcoholic fatty liver disease. Hepatology. 30(4). 847–850. 183 indexed citations

15.

Ong, Janus P., David S. Barnes, Zobair M. Younossi, et al.. (1999). Outcome of De Novo hepatitis C virus infection in heart transplant recipients. Hepatology. 30(5). 1293–1298. 59 indexed citations

16.

Ong, Janus P., David S. Barnes, Zobair M. Younossi, et al.. (1999). SEVERE CHOLESTATIC HEPATITIS IN HEART TRANSPLANT RECIPIENTS OF HEPATITIS C VIRUS (HCV)-ANTIBODY POSITIVE (+) DONORS. Transplantation. 67(7). S216–S216. 1 indexed citations

17.

Younossi, Zobair M., Terry Gramlich, Y. C. Liu, et al.. (1998). Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations.. PubMed. 11(6). 560–5. 265 indexed citations

18.

Gramlich, Terry, et al.. (1998). Clinico-pathologic features of non-alcoholic fatty liver disease predicting outcome. Gastroenterology. 114. A1370–A1370.

19.

Gramlich, Terry, et al.. (1998). Nonalcoholic fatty liver disease: Risk factors and long-term outcomes for benign versus aggressive disease. Gastroenterology. 114. A1298–A1298. 2 indexed citations

20.

Steffen, Rita, et al.. (1997). Autoimmune Enteropathy in a Pediatric Patient: Partial Response to Tacrolimus Therapy. Clinical Pediatrics. 36(5). 295–299. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact